medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2008, Number 10

<< Back Next >>

Ginecol Obstet Mex 2008; 76 (10)

Hypothyroidism associated to menopause symptoms worsening change with thyroid substitution therapy

Hernández VM, Córdova PN, Zárate A, Basurto L, Manuel AL, Ruiz M, Vargas C, Vargas A

Language: Spanish
References: 16
Page: 571-575
PDF size: 202.24 Kb.


ABSTRACT

Background: Hypothyroidism is more frequent in woman and raises with age. It is not clear why do they have greater susceptibility, but it seems to be related with levels of estrogens and hormonal changes.
Objective: To evaluate changes in symptoms of women with menopause and hypothyroidism after receiving hypothyroidism therapy and later hormonal therapy.
Patients and methods: Longitudinal, descriptive and comparative study. Two groups were formed: one with 27 patients with hypothyroidism diagnoses and menopause, and the other with 27 menopausal patients matched by age. Appraisal criterion of hormonal therapy efficacy was Greene scale. Levotiroxine was employed as hypothyroidism therapy, at doses required to get euthyroidism in each patient.
Results: Basal climacteric symptoms’ intensity was higher in patients with menopause and hypothyroidism, which decrease significantly (p ‹ 0.05) after hypothyroidism therapy.
Conclusions: Climacteric symptoms are more intense in patients with hypothyroidism, but they fall when euthyroidism is maintained. These changes in thyroid function can be associated to changes in estrogens concentrations, and therefore in direct relation to TRH neurohormone (thyroid releasing hormones).


REFERENCES

  1. Rallisonn ML, Dobyns BM, Meikle AW. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 1991;91:363-9.

  2. Zárate A, Saucedo R, Basurto L, Hernández-Valencia M. Principales problemas de salud en la mujer adulta. Acta Med Gpo Ang 2006;4:57-60.

  3. Kabadi UM. Subclinical hypothyroidism. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993;153:957-61.

  4. Gaches F, Delaire L, Nadalon S, Loustaud-Ratt V, Vidal E. Frequency of autoimmune diseases in 218 patients with autoimmune thyroid pathologies. Rev Med Interne 1998;19:173-9.

  5. Weetman P. Autoimmune thyroiditis: predisposition and pathogenesis. Clin Endocrinol 1992;36:307-23.

  6. Burrow GN, Fisher DA, Larson PR. Maternal and fetal thyroid function. N Engl J Med 1994;331:1072-8.

  7. Davies TF. The thyroid immunology of the postpartum period. Thyroid 1999;9:675-84.

  8. Hernández-Valencia M, Zárate A. Amenorrea y trastornos de la menstruación. Acta Med Gpo Ang 2006;4:197-201.

  9. Laufer MR, Floor AE, Parsons KE, Kuntz KM, Barbieri RL. Hormone testing in women with adult onset amenorrhea. Gynecol Obstet Invest 1995;40:200-3.

  10. Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol 2003;17:79-85.

  11. Zárate A, Basurto L, Hernández-Valencia M. Los trastornos tiroideos en la mujer. Ginecol Obstet Mex 2001;69:200-5.

  12. Kudson TM, Meuleman E. Managing menopause. Am Fam Phys 2000;61:1391-440.

  13. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25-31.

  14. Tietz NW. Química clínica. 1a ed. México: McGraw Hil-Interamericana, 1972;pp:593-5.

  15. Hernández-Valencia M, Basurto L, Saucedo R, Vargas C y col. Efecto clínico de las diferentes vías de la terapia de reemplazo hormonal. Acta Med Gpo Ang 2005;3:149-53.

  16. Pines A, Dotan I, Tabori U, Villa Y, et al. L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism. Gynecol Endocrinol 1999;13:196-201.




2020     |     www.medigraphic.com